Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Brenda, Ernst"'
Autor:
Reya Sharman, MD, MPH, Zoey Harris, MD, Brenda Ernst, MD, Dawn Mussallem, DO, Ashley Larsen, MS, Krisstina Gowin, DO
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 8, Iss 2, Pp 166-183 (2024)
Lifestyle factors and their impact on cancer prevention, prognosis, and survivorship are increasingly recognized in the medical literature. Lifestyle factors are primarily defined here as diet and physical activity. We conducted a narrative review of
Externí odkaz:
https://doaj.org/article/c3bd6b217be942f681a754db0d0789cc
Autor:
Remya Raja, Kristina Butler, Marion Curtis, Paul Magtibay, Esen Yonca Bassoy, Tom Rubino, Fabian Coscia, Krista Goergen, Brenda Ernst, Alessandra Schmitt, Ann Oberg
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/f009d9b2b0ef45208f4418d48f31fb23
Autor:
Kaylee Clark, Jamie L. Carroll, Alvaro Moreno-Aspitia, Brenda Ernst, Farah Raheem, Ashley Heil, Beth Boyer, Kristin Mara, Matthew P. Goetz, Roberto A. Leon-Ferre, Karthik V. Giridhar, Jodi Taraba
Publikováno v:
Cancer Research. 83:P4-07
Background: SG was approved in 2020 for the treatment of metastatic triple negative breast cancer (TNBC). The most common grade 3/4 adverse event in the ASCENT trial was neutropenia (51.2%) with a 6% incidence of febrile neutropenia. 1 Package insert
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93f02db6a678d8699007682db2ec7712
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-56
https://doi.org/10.1158/1538-7445.sabcs22-p4-07-56
Autor:
Komal Singh, Keenan Pituch, Qiyun Zhu, Haiwei Gu, Brenda Ernst, Cindy Tofthagen, Melanie Brewer, Kord M. Kober, Bruce A. Cooper, Steven M. Paul, Yvette P. Conley, Marilyn Hammer, Jon D. Levine, Christine Miaskowski
Publikováno v:
Cancer nursing.
Unrelieved chemotherapy-induced nausea (CIN) occurs 48% of patients undergoing chemotherapy and is one of the most debilitating symptoms that patients report.The aims of this study were to identify subgroups of patients with distinct CIN profiles and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a410cb0f2b14e4b049dcdae1fc9b577c
https://pubmed.ncbi.nlm.nih.gov/35671438
https://pubmed.ncbi.nlm.nih.gov/35671438
Autor:
Cindy, Tofthagen, Adam, Perlman, Pooja, Advani, Brenda, Ernst, Judith, Kaur, Winston, Tan, Katharine, Sheffield, John, Crump, Joshua, Henry, Jason, Starr
Publikováno v:
Journal of Palliative Medicine. 25:1563-1570
biBackground:/i/bThirty-six states, including Florida, have legalized marijuana for medical and/or recreational use, yet how it is used and perceived by persons with cancer is not well understood.biObjectives:/i/bThe purpose of this study was to iden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::479a1f926d50658d1ba069fd6dd39a0e
https://doi.org/10.1089/jpm.2022.0100
https://doi.org/10.1089/jpm.2022.0100
Autor:
Karthik V Giridhar, Ethan S Sokol, Peter T Vedell, Jason P Sinnwell, Aakash Desai, Tufia C Haddad, Ciara C O’Sullivan, Roberto A Leon-Ferre, Siddhartha Yadav, Kostandinos Sideras, Brenda Ernst, Minetta C Liu, Abe Eyman Casey, Xiaojia Tang, Zoe Fleischmann, Karthikeyan Murugesan, Krishna R Kalari, Matthew P Goetz
Publikováno v:
Cancer Research. 82:P3-08
Background: FGFR dysregulation is observed in multiple cancers and targeting FGFR is an emerging therapeutic strategy with FDA approved treatments in bladder and cholangiocarcinoma. Here we examined the prevalence of FGFR mutations, fusions, and high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5ac41d7bba3f59314c21c868f9f3a98
https://doi.org/10.1158/1538-7445.sabcs21-p3-08-02
https://doi.org/10.1158/1538-7445.sabcs21-p3-08-02
Autor:
Karan K. Budhraja, Bradon R. McDonald, Michelle D. Stephens, Tania Contente-Cuomo, Havell Markus, Maria Farooq, Patricia F. Favaro, Sydney Connor, Sara A. Byron, Jan B. Egan, Brenda Ernst, Timothy K. McDaniel, Aleksandar Sekulic, Nhan L. Tran, Michael D. Prados, Mitesh J. Borad, Michael E. Berens, Barbara A. Pockaj, Patricia M. LoRusso, Alan Bryce, Jeffrey M. Trent, Muhammed Murtaza
Publikováno v:
Science Translational Medicine. 15
Genome-wide fragmentation patterns in cell-free DNA (cfDNA) in plasma are strongly influenced by cellular origin due to variation in chromatin accessibility across cell types. Such differences between healthy and cancer cells provide the opportunity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9217435dfd2e5b0d7f114e3bfdb5c257
https://doi.org/10.1126/scitranslmed.abm6863
https://doi.org/10.1126/scitranslmed.abm6863
Publikováno v:
Cancers. 14(17)
Poly-adenosine diphosphate ribose polymerase (PARP) inhibitors (PARPi) are approved for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e65659bf9696490e7dffb3fa8750be96
https://pubmed.ncbi.nlm.nih.gov/36077867
https://pubmed.ncbi.nlm.nih.gov/36077867
Autor:
Niloy Jewel Samadder, Brenda Ernst, Scott H. Okuno, Myra J. Wick, Robert L. Nussbaum, Keith Stewart, Megan M. Hager, Pls Uson Junior, Cindy Azevedo, Douglas L. Riegert-Johnson, Margaret Klint, Michael A. Golafshar, Edward D. Esplin, Donald W. Northfelt, Deborah J. Rhodes, Katie L. Kunze, Sarah Mantia, Natalie Ertz-Archambault
Publikováno v:
Cancer Research. 81:PD10-05
Background: Hereditary factors play a key role in the risk of developing breast cancers. Identification of a germline predisposition can have important implications for treatment decisions, risk-reducing interventions, cancer screening, and testing f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88204478e38afcf78c74948755da7134
https://doi.org/10.1158/1538-7445.sabcs20-pd10-05
https://doi.org/10.1158/1538-7445.sabcs20-pd10-05
Autor:
Marina E. Giurescu, Roxanne Lorans, Molly B. Carnahan, Donald Northfelt, Patricia A. Cronin, Brenda Ernst, Victor J. Pizzitola, William G. Eversman, Karen S. Anderson, Richard E. Sharpe, Barbara A. Pockaj, Bhavika Patel
Publikováno v:
Cancer Research. 81:PS3-23
Background: Contrast-enhanced mammography (CEM) is an emerging breast imaging technique utilizing iodinated contrast to highlight areas of neovascularity. The role of CEM in patients with breast implants has not yet been characterized. We report our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72beeae231f8049f322e5f788d802fab
https://doi.org/10.1158/1538-7445.sabcs20-ps3-23
https://doi.org/10.1158/1538-7445.sabcs20-ps3-23